Clari Vest Asset Management LLC Organogenesis Holdings Inc. Transaction History

Clari Vest Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$4.74 - $8.15 $289 - $497	-61 Reduced 0.09%	64,366 $314,000
Q1 2022 May 04, 2022	BUY	$6.47 - $9.57 $143,802 - $212,702	22,226 Added 52.67%	64,427 $490,000
Q4 2021 Feb 14, 2022	SELL	$9.02 - $13.5 $23,091 - $34,560	-2,560 Reduced 5.72%	42,201 $390,000
Q3 2021 Nov 08, 2021	SELL	$13.71 - $17.18 $26,199 - $32,830	-1,911 Reduced 4.09%	44,761 $637,000
Q2 2021 Aug 09, 2021	BUY	$14.92 - $23.23 $696,346 - $1.08 Million	46,672 New	46,672 $776,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $406M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.